DISCLAIMER
The information and materials accessed through or made available for use on any of our Sites, including, any information about diseases, conditions, treatments, or medicines, are for informational purposes only. The Content is not intended to be and is not a substitute for professional medical advice, diagnosis, or treatment, and your participation on our Sites does not create a healthcare professional-patient relationship. You should consult a doctor or other qualified health care professional regarding any questions you have about your health or before making any decisions related to your health or wellness. Call your doctor or 911 immediately if you think you may have a medical emergency.message sent
email sent successfully
You are receiving this because you have an account on www.oneGRAVESvoice.com | ||
To unsubscribe from these emails, click here |
Trusted Resources: News & Meetings
Latest announcements and gatherings
Sharing and Caring? Perspectives of Multidisciplinary Working Between Endocrinologists and Ophthalmologists in Thyroid Eye Disease
Thyroid eye disease (TED) is an autoimmune condition affecting the orbits and is responsible for significant morbidity including, in rare cases, blindness. Affecting up to 25% of patients with Graves’ (autoimmune thyroid disease with thyrotoxicosis), TED is the most striking extrathyroidal manifestation and can be extremely difficult to treat. Yet, TED can often be undiagnosed for several months, or misdiagnosed, leading to significant delays in patient management.
In 2009, the European Group on Graves’ Orbitopathy (EUGOGO) spearheaded an international drive to improve the care of patients with TED, with the Amsterdam Declaration signed by 84 national and international professional and patient-led organisations, including the British Thyroid Foundation. In the UK, TEAMeD (Thyroid Eye Disease Amsterdam Declaration Implementation Group) was formed to implement these objectives.
Related Content
-
Evidence & EducationPrevention of Overt Hypothyroidism Following Radioactive Iodine Therapy for Graves’ Disease By Early Initiatio...Background: Radioactive iodine (RAI) th...
-
People & PlacesBritish Thyroid AssociationThe British Thyroid Association (BTA) is...
-
Evidence & EducationManagement of Neonates Born to Women With Graves’ Disease: A Cohort StudyObjective: Hyperthyroidism in neonates ...
-
People & PlacesNew York-Presbyterian Brooklyn Methodist HospitalA voluntary, acute-care teaching hospita...
-
Evidence & EducationCancer Mortality Following Treatment for Adult HyperthyroidismContext: High-dose iodine 131 is the tr...
-
People & PlacesJohns Hopkins – Thyroid ClinicThe Johns Hopkins Division of Endocrinol...
-
Evidence & EducationStress Triggers the Onset and the Recurrences of Hyperthyroidism in Patients With Graves’ DiseaseThe aim of this study was to evaluate th...
send a message
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.